These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. The production of chemotactic cytokines in an allogeneic response. The role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3. Lukacs NW; Kunkel SL; Burdick MD; Strieter RM Am J Pathol; 1993 Oct; 143(4):1179-88. PubMed ID: 7692733 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic human monoclonal antibodies in inflammatory diseases. Kotsovilis S; Andreakos E Methods Mol Biol; 2014; 1060():37-59. PubMed ID: 24037835 [TBL] [Abstract][Full Text] [Related]
16. Treatment of inflammatory diseases with a monoclonal antibody to intercellular adhesion molecule 1. Rothlein R; Jaeger JR Ciba Found Symp; 1995; 189():200-8; discussion 208-11. PubMed ID: 7587634 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacology and therapeutic potential of monoclonal antibody treatment in rheumatoid arthritis. Choy EH Drugs Aging; 1998 Feb; 12(2):139-48. PubMed ID: 9509292 [TBL] [Abstract][Full Text] [Related]
18. Targeting interleukin-6 in pediatric rheumatic diseases. De Benedetti F Curr Opin Rheumatol; 2009 Sep; 21(5):533-7. PubMed ID: 19593141 [TBL] [Abstract][Full Text] [Related]
19. Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases. Kalden JR Arthritis Res; 2002; 4 Suppl 2(Suppl 2):S34-40. PubMed ID: 12110156 [TBL] [Abstract][Full Text] [Related]
20. [New immunologic treatment of rheumatoid arthritis]. Sany J Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]